Less than 1% of COPD patients receive pulmonary rehab following hospitalization

Michigan claims data reveals underuse of an effective intervention

10:07 AM

Author | Kelly Malcom

man walking on treadmill in open space with person in blue scrubs and scrub hat
Getty Images

Rehabilitation, or rehab, can help patients who are recovering from an injury or illness manage their conditions and get back to doing the things they love.

However, new data suggests that patients who have been hospitalized for chronic obstructive pulmonary disorder may be missing out on this beneficial step in the healing process.

An exacerbation of COPD is a sudden worsening of symptoms, including shortness of breath, and cough, which can be fatal.

COPD exacerbations led to more than 335,000 hospitalizations in the United States in 2020. 

Studies have shown that pulmonary rehabilitation for COPD can improve quality of life and reduce hospital readmissions.

Michael Thompson, Ph.D., of the Department of Cardiac Surgery at Michigan Medicine worked with U-M surgery resident Whitney W. Fu, M.D., and a team of pulmonologists, general surgeons and clinical researchers to analyze whether patterns of rehab use observed in patients hospitalized for cardiac procedures would be mirrored in patients hospitalized for exacerbations of COPD.

Although rehab improves outcomes for both pulmonary and cardiac patients, usage remains low.

The picture was even bleaker than expected: The overall initiation rate for pulmonary rehab in patients recovering from a COPD hospitalization was just 0.8%.

“We knew things were bad, but obviously we didn’t know things were this bad,” said Thompson.

The team’s insights emerged from claims data from the Michigan Value Collaborative, a Blue Cross Blue Shield of Michigan funded collaborative quality initiative that includes over 100 acute care hospitals and 40 physician organizations across the state of Michigan.

Just over 36,000 patients and 99 hospitals for hospitalizations between 1/1/18-12/31/21 were included in their specific study.

Most of the patients were older than 65, female, white and insured via Medicare, which covers the costs associated with pulmonary rehab.

And while the investigators had hoped the data would reveal characteristics at high-performing hospitals to improve use of pulmonary rehabilitation, there were no high performing hospitals.

“We’re at ground zero in trying to improve awareness and talking to physicians and patients about pulmonary rehab,” he said.

A model for improvement could come from work done to promote cardiac rehabilitation, notes Thompson, which has usage rates of around 30% for patients recovering from heart procedures.

Hospital differences in cardiac rehab are largely practice driven and center specific, bolstered by standard referral packages built into the electronic health record.

Similar tactics could be applied for pulmonary rehab, he adds.

While the COPD findings are only of hospitals based in Michigan, notes Thompson, other national studies have found similar results.

“Our initial takeaway here is that we can start by doing just the bare minimum,” he said.

Although Blue Cross Blue Shield of Michigan and the Michigan Value Collaborative work collaboratively, the opinions, beliefs and viewpoints expressed by the authors do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.

Additional authors: Kristin P. Hassett, Wassim W. Labaki, Thomas S Valley

Paper cited: “Use of Pulmonary Rehabilitation After COPD Hospitalization: An Analysis of Statewide Patient and Hospital Data,” Annals of the American Thoracic Society. DOI: 1.1513/AnnalsATS.202402-196OC  

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.


More Articles About: All Research Topics Chronic obstructive pulmonary disease (COPD) Pulmonology
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories yellow measurement yellow twirled around blue colored money signs and RX bottles and pills and shots
Health Lab
The heart of the question: Who can get Medicare-covered weight loss medicine?
Wegovy (semaglutide) now has Medicare approval for coverage among people with obesity and cardiovascular disease but no diabetes; a study looks at what level of risk might make someone eligible.
holding syringe white shirt close up in hands
Health Lab
Could GLP1RA drugs lower high iron levels?
GLP1RA drugs are used to treat obesity as well as type 2 diabetes. Research from University of Michigan Health finds that these drugs can also be effective in treating high iron levels, a cause and symptom of type 2 diabetes.
machine beige black
Health Lab
Histotripsy liver tumor trial successful, early clinical adoption recommended
The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.
women getting shot in arm sitting with clinican wearing pink shirt
Health Lab
COVID-19 hits older adults hardest; which ones want the updated vaccine?
Older adults face a higher risk of severe COVID-19, but an updated vaccine offers additional protection. A new poll shows which people over 50 are most likely to get it.
purple cells attached and merging
Health Lab
Organoid model predicts bladder cancer treatment response
Researchers have developed a new model to help predict treatment response in patients with bladder cancer. 
rx bottle orange see through person paying in background
Health Lab
New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year
A study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.